-asvir
A hepatitis C NS5A inhibitor.
- Drugs ending in -asvir: 12
- Approved somewhere: 6
- With a US drug page: 1
Approved and clinical-stage drugs in ChEMBL whose names ending in -asvir, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Daclatasvir | Approved | NS5A | Nonstructural protein 5A inhibitor |
| Elbasvir | Approved | NS5A | Nonstructural protein 5A inhibitor |
| Ledipasvir | Approved | NS5A | Nonstructural protein 5A inhibitor |
| Ombitasvir | Approved | NS5A | Nonstructural protein 5A inhibitor |
| Pibrentasvir | Approved | NS5A | Nonstructural protein 5A inhibitor |
| Velpatasvir | Approved | NS5A | Nonstructural protein 5A inhibitor |
| Yimitasvir | Phase 3 | — | — |
| Coblopasvir | Phase 2 | — | — |
| Odalasvir | Phase 2 | NS5A | Nonstructural protein 5A inhibitor |
| Ravidasvir | Phase 2 | NS5A | Nonstructural protein 5A inhibitor |
| Ruzasvir | Phase 2 | NS5A | Nonstructural protein 5A inhibitor |
| Samatasvir | Phase 2 | NS5A | Nonstructural protein 5A inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO